The University of Zaragoza, sometimes referred to as Saragossa University is a public university with teaching campuses and research centres spread over the three provinces of Aragon, Spain. Founded in 1542, it is one of the oldest universities in Spain, with a history dating back to the Roman period.

During the past decade, Universidad de Zaragoza conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidad de Zaragoza" #1 collaborator was "Universidad de Zaragoza" with 2 trials as a collaborator, "ATADES" with 1 trials as a collaborator, "Baker Heart and Diabetes Institute" with 1 trials as a collaborator, "Centre for Research and Technology Hellas" with 1 trials as a collaborator and "EUROPEAN UNION'S HORIZON 2020 RESEARCH AND INNOVATION PROGRAMME (Project Number: 945246)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Universidad de Zaragoza" are "Caffeine" (2 trials), "Athletic Performance" (1 trials), "Biomechanical Parameters" (1 trials), "Bone Structure" (1 trials) and "Cerebral Palsy" (1 trials). Many other conditions were trialed in "Universidad de Zaragoza" in a lesser frequency.

Most popular intervention types in "Universidad de Zaragoza" are "Other" (3 trials), "Behavioral" (2 trials), "Device" (2 trials), "Dietary Supplement" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATLAS 2030 exoskeleton" (1 trials), "Caffeine" (1 trials), "Caffeine supplementation" (1 trials), "Cervical Exercise" (1 trials) and "Control condition" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidad de Zaragoza" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universidad de Zaragoza". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universidad de Zaragoza, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidad de Zaragoza, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".